Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease

Heart Rhythm

Volumn 7, Issue 6, 2010, Pages 740-744

  Inada, Keiichi ^a   Roberts Thomson, Kurt C ^a   Seiler, Jens ^a   Steven, Daniel ^a   Tedrow, Usha B ^a   Koplan, Bruce A ^a   Stevenson, William G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Catheter ablation; Coronary artery disease; Elderly; Mortality; Radiofrequency catheter ablation; Safety; Ventricular tachycardia

Indexed keywords

AMIODARONE; SOTALOL;

ADULT; AGE; AGED; ARTICLE; BLOOD VESSEL INJURY; BRAIN INFARCTION; CARDIOGENIC SHOCK; CATHETER ABLATION; COMPLETE HEART BLOCK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; FEMALE; HEART FAILURE; HEART TAMPONADE; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HUMAN; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SAFETY; SURVIVAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BODY SURFACE POTENTIAL MAPPING; CATHETER ABLATION; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MASSACHUSETTS; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; SEX FACTORS; SOTALOL; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT FAILURE;

EID: 77952547243     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.02.019     Document Type: Article

References (33)

1. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 337 (1997) 1569-1575
2. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. multicenter unsustained tachycardia trial investigators. N Engl J Med 341 (1999) 1882-1890
3. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
4. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
5. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357 (2007) 2657-2665
6. Aliot E.M., Stevenson W.G., Almendral-Garrote J.M., et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11 (2009) 771-817
7. Calkins H., Epstein A., Packer D., et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. cooled RF multi center investigators group. J Am Coll Cardiol 35 (2000) 1905-1914
8. Segal O.R., Chow A.W., Markides V., Schilling R.J., Peters N.S., and Davies D.W. Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm 2 (2005) 474-482
9. Zado E.S., Callans D.J., Gottlieb C.D., et al. Efficacy and safety of catheter ablation in octogenarians. J Am Coll Cardiol 35 (2000) 458-462
10. Kihel J., Da Costa A., Kihel A., et al. Long-term efficacy and safety of radiofrequency ablation in elderly patients with atrioventricular nodal re-entrant tachycardia. Europace 8 (2006) 416-420
11. Epstein L.M., Chiesa N., Wong M.N., et al. Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly. J Am Coll Cardiol 23 (1994) 1356-1362
12. Chen S.A., Chiang C.E., Yang C.J., et al. Accessory pathway and atrioventricular node reentrant tachycardia in elderly patients: clinical features, electrophysiologic characteristics and results of radiofrequency ablation. J Am Coll Cardiol 23 (1994) 702-708
13. Zado E., Callans D.J., Riley M., et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 19 (2008) 621-626
14. Panotopoulos P.T., Axtell K., Anderson A.J., et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 29 (1997) 556-560
15. Stevenson W.G., Friedman P.L., Kocovic D., Sager P.T., Saxon L.A., and Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 98 (1998) 308-314
16. Soejima K., Suzuki M., Maisel W.H., et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation 104 (2001) 664-669
17. Brunckhorst C.B., Delacretaz E., Soejima K., Maisel W.H., Friedman P.L., and Stevenson W.G. Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation 110 (2004) 652-659
18. Sosa E., Scanavacca M., d'Avila A., Oliveira F., and Ramires J.A. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 35 (2000) 1442-1449
19. Zei P.C., and Stevenson W.G. Epicardial catheter mapping and ablation of ventricular tachycardia. Heart Rhythm 3 (2006) 360-363
20. Soejima K., Delacretaz E., Suzuki M., et al. Saline-cooled versus standard radiofrequency catheter ablation for infarct-related ventricular tachycardias. Circulation 103 (2001) 1858-1862
21. Calkins H., Yong P., Miller J.M., et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr multicenter investigators group. Circulation 99 (1999) 262-270
22. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 119 (2009) e21-e181
23. Rich M.W. Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. Am J Geriatr Cardiol 15 (2006) 7 11
24. Chan P.S., Nallamothu B.K., Spertus J.A., et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2 (2009) 16-24
25. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
26. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
27. Cardiac arrest in Seattle: conventional versus amiodarone drug evaluation (the CASCADE study). Am J Cardiol 67 (1991) 578-584
28. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 295 (2006) 165-171
29. Kitzman D.W., Scholz D.G., Hagen P.T., Ilstrup D.M., and Edwards W.D. Age-related changes in normal human hearts during the first 10 decades of life. part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 63 (1988) 137-146
30. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 107 (2003) 346-354
31. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 107 (2003) 139-146
32. Della Bella P., Riva S., Fassini G., et al. Incidence and significance of pleomorphism in patients with postmyocardial infarction ventricular tachycardia. acute and long-term outcome of radiofrequency catheter ablation. Eur Heart J 25 (2004) 1127-1138
33. Stevenson W.G., Wilber D.J., Natale A., Jackman W.M., et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter Thermocool ventricular tachycardia ablation trial. Circulation 118 (2008) 2773-2782